Arvinas, Inc. (ARVN) Financials

ARVN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.3 billion 644.6 million
2023-09-30 1.1 billion 601.1 million
2023-06-30 1.1 billion 619.9 million
2023-03-31 1.2 billion 664.8 million

ARVN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -83.2 million 16.7 million
2023-09-30 -85.9 million 16.7 million
2023-06-30 -89.3 million 18.3 million
2023-03-31 -92.3 million 19.9 million

ARVN Net Income

No data available :(

ARVN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.3 billion - 2.4 million
2023-09-30 998.5 million - 3.0 million
2023-06-30 1.0 billion 900000 3.5 million
2023-03-31 1.1 billion 900000 4.0 million

ARVN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 61.1 million
2023-09-30 54.1 million
2023-06-30 53.4 million
2023-03-31 53.3 million

ARVN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 100000 95.2 million 27.0 million 1.7 million
2023-09-30 1.1 million 85.9 million 22.6 million -
2023-06-30 600000 103.4 million 25.7 million -
2023-03-31 1.1 million 95.3 million 24.9 million -

ARVN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 -43.1 million 1.7 million
2023-09-30 34.6 million 1.7 million
2023-06-30 54.5 million 1.6 million
2023-03-31 32.5 million 1.7 million

ARVN

Price: $32.43

52 week price:
13.57
53.08

Earnings Per Share: -6.62 USD

P/E Ratio: -9.50

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 476209

Market Capitalization: 2.3 billion

Links: